Huntington's Disease Linked to Dysfunction of Subthalamic Nucleus in the Brain

Early problems in the subthalamic nucleus contribute to Huntington's disease symptoms, and may impair the processing capacity and health of other brain structures.

Huntington's disease is characterized by the progressive loss of nerve cells in the brain and affects approximately one in 10,000 people. This fatal disorder is caused by a hereditary defect in a single gene.

The debilitating symptoms of Huntington's disease typically manifest in adulthood and involve loss of motor and cognitive function, depression and personality changes. From the point of onset, symptoms develop and intensify over the following 10 to 25 years until death, typically due to complications associated with the disease.

Huntington's Disease | Huntington's Chorea - Causes, Symptoms, Diagnosis, Treatment
Huntington’s disease is a genetic degenerative disorder that affects the brain and causes psychiatric, motor and cognitive dysfunction. Learn about causes, symptoms and treatment

‘Patients with Huntington's disease have fewer nerve cells in the subthalamic nucleus, a group of brain structures critical for movement and impulse control.’

Currently, there is no cure for Huntington's disease; treatment can only alleviate some of the symptoms.

Northwestern Medicine scientists identified a link between Huntington's disease and dysfunction of the subthalamic nucleus, a component of the basal ganglia, a group of brain structures critical for movement and impulse control. "Although the genetic basis of the disease is well established, why the mutation leads to the expression of symptoms and loss of brain tissue remains poorly understood," explained senior author Mark Bevan, professor of physiology at Northwestern University Feinberg School of Medicine.

The study was published in the journal eLife.

New Method Found That Slows the Progression of Huntington's Disease
Human glia transplanted into mice with the Huntington's disease mutation appeared to keep neurons healthier and extended the animals survival.

"While research into Huntington's disease has focused on other parts of the basal ganglia, the subthalamic nucleus has been largely overlooked," said Bevan. "This is surprising because patients with Huntington's disease have fewer nerve cells in the subthalamic nucleus. People who have suffered damage to the subthalamic nucleus exhibit excessive movement and impulsive behavior, similar to patients with Huntington's disease."

Using mice genetically engineered to carry the Huntington's disease gene, scientists discovered the electrical activity of the subthalamic nucleus was lost. Furthermore, impaired subthalamic activity was caused by anomalous receptor signaling, leading to defective energy metabolism and accumulation of damaging oxidants.

Drug Deutetrabenazine Helps Control Sudden Movements of Huntington Disease
To control a prominent symptom of Huntington disease, chorea, researchers evaluated the efficacy and safety of the drug deutetrabenazine.

The authors also found abnormalities in the subthalamic nucleus occur earlier than in other brain regions, and that subthalamic nucleus nerve cells progressively degenerate as the mice age, mirroring the human pathology of Huntington's disease.

"Our findings suggest early problems in the subthalamic nucleus not only contribute to the symptoms of Huntington's disease, but are also likely to impair the processing capacity and health of other brain structures, more traditionally associated with the disease," Bevan said.

Failure to Destroy Toxic Protein Contributes to Huntington's Disease
Names forever linked to what they represent: Alzheimer's, Huntington's, Parkinson's: diseases that ravage the brain's neurons and leave entire regions to wither and die.

A better understanding of aberrant brain receptor signaling that leads to nerve cell dysfunction could reveal a target for therapy, according to the authors.

Source-Eurekalert